MEF2B
Myocyte-specific enhancer factor 2B
Also known as: MEF2B_HUMAN, RSRFR2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02080
- Gene
- MEF2B
- Ensembl
- ENSG00000213999
- Chromosome
- 19
- Canonical length
- 365 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cell Junctions,Cytosol
OverviewNCBI Gene
This gene represents numerous read-through transcripts that span GeneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitiation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus. At least one additional MEF2B variant and isoform can be expressed from a downstream promoter, and is annotated on GeneID:100271849. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
365 residues, UniProt reviewed canonical sequence.
>Q02080|MEF2B
1 MGRKKIQISR ILDQRNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS ANRLFQYAST
61 DMDRVLLKYT EYSEPHESRT NTDILETLKR RGIGLDGPEL EPDEGPEEPG EKFRRLAGEG
121 GDPALPRPRL YPAAPAMPSP DVVYGALPPP GCDPSGLGEA LPAQSRPSPF RPAAPKAGPP
181 GLVHPLFSPS HLTSKTPPPL YLPTEGRRSD LPGGLAGPRG GLNTSRSLYS GLQNPCSTAT
241 PGPPLGSFPF LPGGPPVGAE AWARRVPQPA APPRRPPQSA SSLSASLRPP GAPATFLRPS
301 PIPCSSPGPW QSLCGLGPPC AGCPWPTAGP GRRSPGGTSP ERSPGTARAR GDPTSLQASS
361 EKTQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MEF2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 37 nTPM
- tonsil: 30 nTPM
- appendix: 13 nTPM
- spleen: 10 nTPM
- ovary: 5.6 nTPM
- small intestine: 5.6 nTPM
Single-cell type
- choroid plexus epithelial cells: 36 nCPM
- ependymal cells: 25 nCPM
- astrocytes: 15 nCPM
- microglia: 15 nCPM
- oligodendrocytes: 14 nCPM
- bergmann glia: 13 nCPM
Immune cell
- neutrophil: 0.4 nTPM
- classical monocyte: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- white matter: 7 nTPM
- basal ganglia: 6.1 nTPM
- medulla oblongata: 5.8 nTPM
- thalamus: 5.7 nTPM
- midbrain: 5.1 nTPM
- pons: 4.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MEF2B.
Disease | ImmuneIEDB
Conditions an epitope on MEF2B was assayed in.
- follicular lymphoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.29
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- heart development
- muscle organ development
- positive regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- histone deacetylase binding
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MEF2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MEF2B as an antibody target. Whether an autoantibody or antibody against MEF2B could matter depends on whether native MEF2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MEF2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MEF2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...